Keli Liu
No. 174 Shazheng Street
Tanjiagang, 400044, China
Tanjiagang, 400044, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Curcumin exerts distinct anti-tumor effects mediated by NRF1α from NRF2 via metabolic reprogramming in hepatocellular carcinoma (HepG2).
Journal: Bioorganic chemistry
Published: May 21, 2026
Inhibition of NFE2L1 Enables the Tumor-Associated Macrophage Polarization and Enhances Anti-PD1 Immunotherapy in Glioma.
Journal: CNS neuroscience & therapeutics
Published: February 07, 2025
Deficiency of DDI2 suppresses liver cancer progression by worsening cell survival conditions.
Journal: Free radical biology & medicine
Published: December 22, 2024
Distinct mechanisms by which Nrf1 and Nrf2 as drug targets contribute to the anticancer efficacy of cisplatin on hepatoma cells.
Journal: Free radical biology & medicine
Published: November 26, 2023
Genetic loss of Nrf1 and Nrf2 leads to distinct metabolism reprogramming of HepG2 cells by opposing regulation of the PI3K-AKT-mTOR signalling pathway.
Journal: Bioorganic chemistry
Published: November 05, 2023
Nrf1 is not a direct target gene of SREBP1, albeit both are integrated into the rapamycin-responsive regulatory network in human hepatoma cells.
Journal: PloS one
Published: February 14, 2023
Nrf1 is an indispensable redox-determining factor for mitochondrial homeostasis by integrating multi-hierarchical regulatory networks.
Journal: Redox biology
Published: August 18, 2022
Different Inhibition of Nrf2 by Two Keap1 Isoforms α and β to Shape Malignant Behaviour of Human Hepatocellular Carcinoma.
Journal: International journal of molecular sciences
Published: July 19, 2022
The Role of MicroRNA in the Regulation of Tumor Epithelial-Mesenchymal Transition.
Journal: Cells
Published: May 04, 2022
Differential Yet Integral Contributions of Nrf1 and Nrf2 in the Human HepG2 Cells on Antioxidant Cytoprotective Response against Tert-Butylhydroquinone as a Pro-Oxidative Stressor.
Journal: Antioxidants (Basel, Switzerland)
Published: August 30, 2021
TCF11 Has a Potent Tumor-Repressing Effect Than Its Prototypic Nrf1α by Definition of Both Similar Yet Different Regulatory Profiles, With a Striking Disparity From Nrf2.
Journal: Frontiers in oncology
Published: May 08, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026